CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
9.54
-0.23 (-2.35%)
Apr 16, 2025, 11:33 AM EDT - Market open

CervoMed Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
97.794.096.67
Short-Term Investments
29.92---
Cash & Short-Term Investments
38.927.794.096.67
Cash Growth
399.46%90.37%-38.59%-
Accounts Receivable
2.250.92--
Other Receivables
---0.07
Receivables
2.250.92-0.07
Prepaid Expenses
1.911.260.060.02
Other Current Assets
---0.05
Total Current Assets
43.089.964.166.82
Other Long-Term Assets
-0.01--
Total Assets
43.089.974.166.82
Accounts Payable
1.510.660.10.02
Accrued Expenses
2.251.840.590.4
Current Portion of Long-Term Debt
--12.414.11
Other Current Liabilities
0.120.090.050.03
Total Current Liabilities
3.882.613.164.56
Long-Term Debt
---5.92
Total Liabilities
3.882.613.1610.47
Common Stock
0.010.0100
Additional Paid-In Capital
109.8761.8118.9818.52
Retained Earnings
-70.73-54.44-52.27-46.47
Comprehensive Income & Other
0.06---
Total Common Equity
39.27.38-33.29-27.94
Shareholders' Equity
39.27.38-9-3.66
Total Liabilities & Equity
43.089.974.166.82
Total Debt
--12.4110.03
Net Cash (Debt)
38.927.79-8.32-3.36
Net Cash Growth
399.46%---
Net Cash Per Share
4.822.93-16.06-0.75
Filing Date Shares Outstanding
8.76.174.54.5
Total Common Shares Outstanding
8.75.674.54.5
Working Capital
39.27.37-92.26
Book Value Per Share
4.501.30-7.39-6.21
Tangible Book Value
39.27.38-33.29-27.94
Tangible Book Value Per Share
4.501.30-7.39-6.21
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q